Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05027_nanopub.RA7Zz28Xp0f0lpTPs8ZhJFS-rvYzjJx6Vw014a2TMCsIs#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05027 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05027 label "DG041 [drugbank:DB05027]" assertion.
- drugbank:DB05027 seeAlso DB05027 assertion.
- drugbank:DB05027 description "DG041 is a novel, first-in-class, orally-administered small molecule developmented for the prevention of arterial thrombosis and its complications. DG041, an anti-platelet compound, has shown to be a selective and potent antagonist of the EP3 receptor for prostaglandins E2. EP3 is a target that associates with increased risk of various vascular diseases. It block the formation of blood clots mediated through inflammation in atherosclerotic plaques but without increasing bleeding risk." assertion.
- drugbank:DB05027 identifier "drugbank:DB05027" assertion.
- drugbank:DB05027 title "DG041" assertion.
- drugbank:DB05027 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05027 drugbank_vocabulary:drugbank-id "DB05027" assertion.
- drugbank:DB05027 bio2rdf_vocabulary:x-identifiers.org DB05027 assertion.
- drugbank:DB05027 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05027" assertion.
- drugbank:DB05027 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05027 bio2rdf_vocabulary:identifier "DB05027" assertion.